Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Cancers|October 13, 2021
Ten Year Results of Extensive Nodal Radiotherapy and Moderately Hypofractionated Simultaneous Integrated Boost in Unfavorable Intermediate-, High-, and Very High-Risk Prostate CancerNadia Gisella Di Muzio, Chiara Lucrezia Deantoni, Chiara Brombin, et al.
La Radiologia Medica|November 8, 2021
Radiotherapy at oligoprogression for metastatic castration-resistant prostate cancer patients: a multi-institutional analysisMaurizio Valeriani, Beatrice Detti, Andrei Fodor, et al.
Tumori|April 19, 2025
18F-FDG PET/CT guided salvage radiotherapy strategies for lymph-nodal relapses in gynecological cancers: SBRT vs ENRTAndrei Fodor, Martina Midulla, Chiara Brombin, et al.
Critical Reviews in Oncology/Hematology|December 10, 2013
Salvage therapy of small volume prostate cancer nodal failures: a review of the literatureBerardino De Bari, Filippo Alongi, Michela Buglione, et al.
Physics and Imaging in Radiation Oncology|April 17, 2025
Development and external multicentric validation of a deep learning-based clinical target volume segmentation model for whole-breast radiotherapyMaria Giulia Ubeira-Gabellini, Gabriele Palazzo, Martina Mori, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 9, 2026
Reassessing the risks: toxicity of stereotactic ablative radiotherapy after bevacizumab in oligometastatic ovarian cancer-a new perspective for radiation oncologists?Donato Pezzulla, Maura Campitelli, Raffaella Cioffi, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 24, 2026
Hidden patterns, different outcomes: un-supervised machine-learning clustering in oligometastatic gynecologic cancerSavino Cilla, Francesco Deodato, Donato Pezzulla, et al.
Clinical Breast Cancer|December 27, 2021
Toxicity of Hypofractionated Whole Breast Radiotherapy Without Boost and Timescale of Late Skin Responses in a Large Cohort of Early-Stage Breast Cancer PatientsAndrei Fodor, Chiara Brombin, Paola Mangili, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 24, 2023
Machine-learning prediction of treatment response to stereotactic body radiation therapy in oligometastatic gynecological cancer: A multi-institutional studySavino Cilla, Maura Campitelli, Maria Antonietta Gambacorta, et al.
International Journal of Radiation Oncology, Biology, Physics|May 7, 2023
Efficacy and Safety of Stereotactic Body Radiation Therapy in Oligometastatic Uterine Cancer (MITO-RT2/RAD): A Large, Real-World Study in Collaboration With Italian Association of Radiation Oncology, Multicenter Italian Trials in Ovarian Cancer, and Mario Negri Gynecologic Oncology Group GroupsGabriella Macchia, Donato Pezzulla, Maura Campitelli, et al.
Pageof 8